GAD1 and type 1 diabetes mellitus: Although ICAs can assist in risk determination, confirmation testing with “biochemical” AAbs (GAD, IAA, IA-2, and ZnT8) is recommended in the American Diabetes Association (ADA) Standards of Care and Breakthrough T1D (formerly JDRF) consensus guidance document (4, 13).